JP2008533102A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008533102A5 JP2008533102A5 JP2008501329A JP2008501329A JP2008533102A5 JP 2008533102 A5 JP2008533102 A5 JP 2008533102A5 JP 2008501329 A JP2008501329 A JP 2008501329A JP 2008501329 A JP2008501329 A JP 2008501329A JP 2008533102 A5 JP2008533102 A5 JP 2008533102A5
- Authority
- JP
- Japan
- Prior art keywords
- leucine
- acetyl
- unilateral
- nerve
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000011580 syndromic disease Diseases 0.000 claims 18
- 229960000669 acetylleucine Drugs 0.000 claims 17
- 210000005036 nerve Anatomy 0.000 claims 14
- 230000001154 acute effect Effects 0.000 claims 12
- WXNXCEHXYPACJF-ZETCQYMHSA-N N-acetyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(C)=O WXNXCEHXYPACJF-ZETCQYMHSA-N 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 9
- 210000000860 cochlear nerve Anatomy 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 6
- 238000001990 intravenous administration Methods 0.000 claims 4
- 230000001953 sensory effect Effects 0.000 claims 4
- 208000027601 Inner ear disease Diseases 0.000 claims 2
- 206010030113 Oedema Diseases 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000005540 biological transmission Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000006835 compression Effects 0.000 claims 2
- 238000007906 compression Methods 0.000 claims 2
- 208000002173 dizziness Diseases 0.000 claims 2
- 230000036540 impulse transmission Effects 0.000 claims 2
- 208000028867 ischemia Diseases 0.000 claims 2
- 206010029864 nystagmus Diseases 0.000 claims 2
- 238000002271 resection Methods 0.000 claims 2
- 230000000472 traumatic effect Effects 0.000 claims 2
- 208000027491 vestibular disease Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0502696A FR2883180B1 (fr) | 2005-03-18 | 2005-03-18 | Utilisation de l'acetyl-leucine pour la preparation d'un medicament destine au traitement de troubles de l'equilibre |
| PCT/EP2006/060841 WO2006097527A1 (fr) | 2005-03-18 | 2006-03-17 | Utilisation de l'acétyl-leucine pour la préparation d'un médicament destiné au traitement de troubles de l'équilibre |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013081360A Division JP2013173759A (ja) | 2005-03-18 | 2013-04-09 | 平衡障害の治療用薬剤の製造のためのアセチル−ロイシンの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008533102A JP2008533102A (ja) | 2008-08-21 |
| JP2008533102A5 true JP2008533102A5 (https=) | 2009-04-30 |
Family
ID=35134794
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008501329A Pending JP2008533102A (ja) | 2005-03-18 | 2006-03-17 | 平衡障害の治療用薬剤の製造のためのアセチル−ロイシンの使用 |
| JP2013081360A Pending JP2013173759A (ja) | 2005-03-18 | 2013-04-09 | 平衡障害の治療用薬剤の製造のためのアセチル−ロイシンの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013081360A Pending JP2013173759A (ja) | 2005-03-18 | 2013-04-09 | 平衡障害の治療用薬剤の製造のためのアセチル−ロイシンの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080108702A1 (https=) |
| EP (1) | EP1865943A1 (https=) |
| JP (2) | JP2008533102A (https=) |
| CA (1) | CA2601101A1 (https=) |
| FR (1) | FR2883180B1 (https=) |
| WO (1) | WO2006097527A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TN2010000251A1 (fr) * | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| ES2994242T3 (en) * | 2016-04-19 | 2025-02-05 | Intrabio Ltd | Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility |
| DK3359146T3 (en) * | 2016-08-11 | 2019-04-08 | Intrabio Ltd | PHARMACEUTICAL COMPOSITIONS AND USES AGAINST LYSOSOMAL STORAGE DISEASES |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3455638B2 (ja) * | 1996-02-23 | 2003-10-14 | 株式会社モリタ製作所 | 平衡機能検査装置 |
| FR2749512B1 (fr) * | 1996-06-10 | 1999-08-13 | Pf Medicament | Utilisation de l'acetyl dl leucine pour le traitement des tremblements |
| ID29095A (id) * | 1998-10-02 | 2001-07-26 | Novartis Ag Cs | Antagonis mglur5 untuk pengobatan rasa sakit dan kegelisahan |
| WO2004096256A1 (en) * | 2001-01-23 | 2004-11-11 | The United States Of America, As Represented By The Secretary Of The Navy | Methods for preventing and treating loss of balance function due to oxidative stress |
-
2005
- 2005-03-18 FR FR0502696A patent/FR2883180B1/fr not_active Expired - Lifetime
-
2006
- 2006-03-17 CA CA002601101A patent/CA2601101A1/fr not_active Abandoned
- 2006-03-17 WO PCT/EP2006/060841 patent/WO2006097527A1/fr not_active Ceased
- 2006-03-17 US US11/886,419 patent/US20080108702A1/en not_active Abandoned
- 2006-03-17 JP JP2008501329A patent/JP2008533102A/ja active Pending
- 2006-03-17 EP EP06725137A patent/EP1865943A1/fr not_active Withdrawn
-
2013
- 2013-04-09 JP JP2013081360A patent/JP2013173759A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20160189T1 (hr) | Liječenje crohnove bolesti lakvinimodom | |
| JP2015512406A5 (https=) | ||
| JP2012236849A5 (https=) | ||
| MX2012007410A (es) | Compuestos antivirales novedosos. | |
| EA200800798A1 (ru) | Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха | |
| CY1110495T1 (el) | Χρηση ενος αγωνιστη υποδοχεα nmda για τη θεραπεια εμβοης που προκαλειται απο κοχλιακη διεγερτοτοξικοτητα | |
| JP2007519649A5 (https=) | ||
| WO2008040534A3 (en) | Non-mucoadhesive film dosage forms | |
| EA200800056A1 (ru) | Каннабиноидный активный фармацевтический ингредиент для лекарственных форм | |
| HRP20110800T1 (hr) | UPORABA 2-6-(3-AMINO-PIPERIDIN-1-IL)-3-METIL-2,4-DIOKSO-3,4-DIHIDRO-2H-PIRIMIDIN-1-ILMETIL-4-FLUORO-BENZONITRILA ZA LIJEČENJE DIJABETESA, RAKA, AUTOIMUNIH POREMEĆAJA I ZARAZE HIV-om | |
| JP2010522137A5 (https=) | ||
| JP2011519821A5 (ja) | 動脈瘤性くも膜下出血及び血管痙攣に対する医薬組成物 | |
| FR2878161B1 (fr) | Forme medicamenteuse orale, solide et concue pour eviter le mesusage | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| JP2020505432A5 (https=) | ||
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| JP2012502915A5 (https=) | ||
| JP2017105861A5 (https=) | ||
| WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
| JP2015522077A5 (https=) | ||
| JP2007119497A5 (https=) | ||
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| JP2011500589A5 (https=) | ||
| EA201100916A1 (ru) | Комбинация инсулина с триазиновыми производными и их применение для лечения диабета | |
| JP2008533102A5 (https=) |